Download
1 / 4
40 likes | 42 Views
The global tumor ablation market is estimated to garner a revenue of around USD 5 billion by the end of 2033 by growing at a CAGR of ~14% over the forecast period, i.e., 2023 u2013 2033.
E N D
Global Tumor Ablation Market to be Propelled by CAGR of ~14% During 2023 – 2033, by the High Prevalence of Cancer Worldwide, and the Steady Growth intheGeriatric Population Kenneth Research published a report titled “Tumor Ablation Market: Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the global tumorablation marketintermsof marketsegmentation bymodeoftreatment, application, technology,and byregion. Further,for thein-depthanalysis, thereportencompasses theindustry growth indicators,restraints,supplyanddemandrisk,alongwithdetaileddiscussiononcurrent and future markettrends thatareassociated withthegrowthofthemarket. The global tumor ablation market is expected to hold a revenue of ~ USD 5 billion by 2033,growingfrom~USD2billionin2022.Themarketgrowthcanbeattributedtothe wide prevalence of cancer, the growth in the elderly population, the considerable rise of hospitalsworldwide,largeinvestments inhealthcare,and thegrowthofdiagnostic imaging procedures.
The global tumor ablation market is expected to grow at a CAGR of approximately 14% from 2023-2033. The market is segmented byapplication into kidney cancer,liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Of these, the liver cancersegmentisanticipatedtoholdthelargestmarketsharebytheendof2033,owing tothewideoccurrenceofprimarylivercancer andbileduct cancer. For moreinformations@https://www.kennethresearch.com/report-details/global- tumor-ablation-market/10070594 The global tumor ablation market is divided into five major regions, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is projected to hold the largest market share by the end of 2033, backed byincreasingcancercases,medicalreimbursements,governmentaidforhealthcare,and high purchasingpower parity. The research is global in nature and covers detailed analysis on the market in North America(U.S.,Canada),Europe(U.K.,Germany,France,Italy,Spain,Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest ofLatinAmerica),Asia-Pacific(China,India,Japan,SouthKorea,Indonesia,Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth&opportunityanalysis,marketplayers’competitivestudy,investment opportunities,demandforfutureoutlooketc.hasalsobeencoveredanddisplayedinthe researchreport. Steadily GrowingGeriatricPopulationtoBoosttheMarketGrowth The population aged 60 and above is estimated to reach 23% of the total population by 2050. It hasbeenobserved thattherehasbeena parallel growthin thenumberof old patients withcanceralongwiththegrowthinthegeriatricpopulation.However,cancertreatment
for older patients is challenging due to the variations that could be observed among the general health and functional status of the group. This is what will increase the demand fortumorablationtreatmentwithitsminimallyinvasivemethodsinthetreatmentofold patients. However, large expenses involved in the treatment, lack of skilled professionals, and stringentgovernmentregulationsareexpectedtooperateaskeyrestraintstothegrowth oftheglobaltumorablation market overtheforecast period. This report also provides the existing competitive scenario of some of the key players of the global tumor ablation market which includes company profiling of Medtronic plc, AngioDynamics, Inc., HealthTronics, Inc., Boston Scientific Corporation, EDAP TMS SA, Sonablate Corporation, Misonix, Inc., Smith & Nephew PLC, THERACLION S. A., BIOTRONIK SE & Co. KG, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global tumor ablation market that will help industry consultants, equipment manufacturers,existingplayerssearchingfor expansionopportunities,new players searching possibilities and other stakeholders to align their market centric strategies according totheongoing andexpectedtrends in thefuture. RequestReport Sample@https://www.kennethresearch.com/sample-request- 10070594 KennethResearch isaleadingserviceproviderfor strategicmarketresearch and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order toavoid futureuncertainties. Contact formoreInfo:
AJDaniel Email: sales@kennethresearch.com U.S.Phone: +1313462 0609
